HuR promotes CRC progression by mediating post-transcriptional gene expression through nucleocytoplasmic shuttling, cytoplasmic mRNA stabilization, splicing regulation, and phosphorylation-dependent interactions with ncRNAs and RBPs, as summarized in Figure 2. The gene discussed is ELAVL1; the disease is colorectal carcinoma.